Monopar Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 137.4%
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics shares were halted due to a circuit breaker as the stock surged by 137.4%.
October 24, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Monopar Therapeutics experienced a significant stock price increase of 137.4%, leading to a trading halt due to a circuit breaker.
The stock price of Monopar Therapeutics surged by 137.4%, triggering a circuit breaker halt. This indicates a strong positive market reaction, likely due to favorable news or developments related to the company.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100